Markets › United States › NAS › GALT

Galectin Therapeutics Inc

NAS:GALTHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$3.50−3.45%At closeAt close · Tue 20 Oct · ≈ AED 12.84 · Market cap $352.47M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−97.0%	−1,166.9%	120.4%	68.2%	45.6%	24.4%	24.4%	+0.0 pts
Return on assets	−79.3%	−73.0%	−182.2%	−145.6%	−268.9%	−157.9%	−157.9%	+0.0 pts
Return on capital employed	−96.9%	−92.0%	−463.6%	−304.0%	236.9%	−174.6%	—	—
Debt / equity	0.0×	11.1×	−1.2×	−1.2×	−1.0×	−1.1×	−1.1×	+0.0%
Debt / assets	0.1%	69.5%	187.3%	254.6%	607.3%	684.8%	—	—
Interest coverage	−269.5×	−61.7×	−37.1×	−13.6×	−7.7×	−2.7×	—	—
Current ratio	5.5×	4.6×	1.6×	1.8×	0.5×	2.4×	2.4×	+0.0%
Quick ratio	5.5×	4.6×	1.6×	1.8×	0.5×	2.4×	—	—
Cash ratio	5.0×	4.4×	1.4×	1.6×	0.4×	2.2×	2.2×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	−0.6%	−0.6%	0.0%	0.0%	−0.2%	0.0%	—	—